180 Life Sciencs

180 Life Sciences Provides Update on Correspondence Received from U.K. and U.S. Regulatory Authorities on Pathway for a Therapy That Could Prevent Progression of Early-Stage Dupuytren’s Disease
BioSpace
Tue, 06/14/22 - 09:00 pm
180 Life Sciencs
FDA
MHRA
Dupuytren's Contracture
Dupuytren's disease
adalimumab